X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13693) 13693
Publication (763) 763
Newsletter (250) 250
Newspaper Article (81) 81
Magazine Article (42) 42
Book Chapter (39) 39
Book Review (37) 37
Conference Proceeding (14) 14
Book / eBook (10) 10
Dissertation (7) 7
Trade Publication Article (4) 4
Government Document (3) 3
Web Resource (3) 3
Data Set (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (7152) 7152
animals (7039) 7039
humans (5651) 5651
female (4967) 4967
urea (4390) 4390
index medicus (3999) 3999
blood urea nitrogen (3900) 3900
rats (3638) 3638
adult (2296) 2296
creatinine - blood (2290) 2290
middle aged (2234) 2234
urea - blood (1914) 1914
aged (1524) 1524
mice (1491) 1491
kidney - drug effects (1374) 1374
pharmacology & pharmacy (1370) 1370
urea - administration & dosage (1360) 1360
time factors (1307) 1307
urea - metabolism (1264) 1264
urea - analogs & derivatives (1236) 1236
rats, wistar (1037) 1037
dietary proteins - administration & dosage (1010) 1010
dose-response relationship, drug (1000) 1000
kidney - pathology (958) 958
oxidative stress (951) 951
creatinine (948) 948
metabolism (917) 917
urea - pharmacology (906) 906
research (886) 886
administration, oral (879) 879
kidney - metabolism (854) 854
rats, sprague-dawley (845) 845
urology & nephrology (821) 821
rodents (807) 807
kidneys (774) 774
liver (765) 765
analysis (755) 755
toxicology (738) 738
body weight (729) 729
nitrogen - metabolism (721) 721
proteins (713) 713
disease models, animal (710) 710
health aspects (690) 690
agriculture, dairy & animal science (688) 688
diet (686) 686
adolescent (665) 665
treatment outcome (640) 640
toxicity (637) 637
physiological aspects (626) 626
research article (619) 619
medicine (599) 599
urea - urine (595) 595
liver - metabolism (587) 587
kidney (581) 581
physiology (578) 578
inflammation (575) 575
antioxidants (572) 572
blood (566) 566
nephrotoxicity (566) 566
liver - drug effects (565) 565
urea - therapeutic use (550) 550
enzymes (538) 538
biochemistry & molecular biology (535) 535
glucose (513) 513
nitrogen (508) 508
body weight - drug effects (486) 486
kidney diseases - chemically induced (486) 486
random allocation (485) 485
nutrition & dietetics (481) 481
cattle (458) 458
urine (456) 456
food science & technology (454) 454
pregnancy (440) 440
expression (437) 437
multidisciplinary sciences (436) 436
medicine, research & experimental (435) 435
apoptosis (430) 430
blood glucose - metabolism (429) 429
care and treatment (428) 428
kinetics (427) 427
blood glucose - analysis (426) 426
dogs (425) 425
injections, intravenous (421) 421
amino acids (412) 412
prospective studies (406) 406
child (405) 405
dietary supplements (405) 405
oxidative stress - drug effects (405) 405
ammonia (396) 396
kidney diseases (391) 391
animal feed (390) 390
aspartate aminotransferases - blood (390) 390
mortality (385) 385
kidney function tests (384) 384
rat (378) 378
rats, inbred strains (374) 374
alanine transaminase - blood (368) 368
protein (365) 365
science (365) 365
diabetes (361) 361
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13116) 13116
German (314) 314
Japanese (169) 169
Russian (119) 119
French (104) 104
Chinese (62) 62
Spanish (61) 61
Polish (40) 40
Italian (37) 37
Czech (19) 19
Slovak (15) 15
Portuguese (10) 10
Korean (8) 8
Dutch (6) 6
Swedish (6) 6
Turkish (6) 6
Ukrainian (6) 6
Danish (5) 5
Norwegian (3) 3
Serbian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Persian (2) 2
Romanian (2) 2
Finnish (1) 1
Greek (1) 1
Hebrew (1) 1
Hungarian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Internal Medicine, ISSN 0953-6205, 2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | 14-DAY TRIPLE | 1ST-LINE TREATMENT | MULTICENTER | METAANALYSIS | REGIMEN | STANDARD TRIPLE THERAPY | RATES | MEDICINE, GENERAL & INTERNAL | INFECTION | HYBRID THERAPY | DURATION | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10058, pp. 2355 - 2365
Summary Background Whether concomitant therapy is superior to bismuth quadruple therapy or 14-day triple therapy for the first-line treatment of Helicobacter... 
Internal Medicine | CLARITHROMYCIN | ESOMEPRAZOLE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EFFICACY | GASTRIC-CANCER | RESISTANCE | SEQUENTIAL THERAPY | INFECTION | ERADICATION | METRONIDAZOLE | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Proton Pump Inhibitors - administration & dosage | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Organometallic Compounds - therapeutic use | Female | Urea - metabolism | Amoxicillin - administration & dosage | Lansoprazole - administration & dosage | Drug Administration Schedule | Metronidazole - administration & dosage | Breath Tests | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Proton Pump Inhibitors - therapeutic use | Amoxicillin - therapeutic use | Taiwan | Drug Therapy, Combination - statistics & numerical data | Lansoprazole - therapeutic use | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Organometallic Compounds - administration & dosage | Clinical trials | Medical colleges | Helicobacter infections | Care and treatment | Helicobacter pylori | Antiulcer drugs | Analysis | Bacteria | Bacterial infections | Antibiotics | Drug resistance | Drug therapy
Journal Article
Journal Article
Journal Article
Digestive Diseases and Sciences, ISSN 0163-2116, 2/2015, Volume 60, Issue 2, pp. 458 - 464
Helicobacter pylori eradication is a challenge in penicillin allergy.To assess the efficacy and safety of first-line and rescue treatments in patients allergic... 
Biochemistry, general | Levofloxacin | Allergy | Quinolone | Oncology | Eradication | Allergic | Transplant Surgery | Medicine & Public Health | Helicobacter pylori | Hepatology | Gastroenterology | Penicillin | Bismuth | CLARITHROMYCIN | ANTIBIOTIC-RESISTANCE | QUADRUPLE THERAPY | PROTON PUMP INHIBITOR | TRIPLE THERAPY | INFECTION | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | TREATMENT FAILURE | Predictive Value of Tests | Bismuth - administration & dosage | Prospective Studies | Humans | Middle Aged | Salvage Therapy | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Proton Pump Inhibitors - administration & dosage | Time Factors | Antacids - adverse effects | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Penicillins - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Levofloxacin - administration & dosage | Drug Hypersensitivity - etiology | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Breath Tests | Treatment Outcome | Spain | Medication Adherence | Helicobacter pylori - isolation & purification | Antacids - administration & dosage | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Helicobacter Infections - microbiology | Urea | Antibacterial agents | Allergic reaction
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 01/2010, Volume 31, Issue 2, pp. 336 - 348
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9790, pp. 507 - 514
Journal Article
ANNALS OF PHARMACOTHERAPY, ISSN 1060-0280, 08/2017, Volume 51, Issue 8, pp. 682 - 695
Objective: To summarize and evaluate the existing literature regarding medications to treat Parkinson's disease (PD) psychosis. Data Sources: MEDLINE (1946 to... 
Parkinson's disease | MANAGEMENT | DOPAMINERGIC-INDUCED HALLUCINATIONS | quetiapine | psychosis | TRIAL | olanzapine | PHARMACOKINETICS | pimavanserin | DOUBLE-BLIND | clozapine | PHARMACOLOGY & PHARMACY | UPDATE | Piperazines - administration & dosage | Clozapine - therapeutic use | Antipsychotic Agents - adverse effects | Clozapine - administration & dosage | Humans | Thiazoles - administration & dosage | Parkinson Disease - drug therapy | Thiazoles - therapeutic use | Thiazoles - adverse effects | Risperidone - therapeutic use | Antipsychotic Agents - therapeutic use | Urea - analogs & derivatives | Risperidone - adverse effects | Urea - administration & dosage | Quetiapine Fumarate - adverse effects | Piperidines - administration & dosage | Psychotic Disorders - psychology | Risperidone - administration & dosage | Piperazines - therapeutic use | Evidence-Based Medicine | Parkinson Disease - psychology | Piperazines - adverse effects | Quetiapine Fumarate - therapeutic use | Randomized Controlled Trials as Topic | Antipsychotic Agents - administration & dosage | Quetiapine Fumarate - administration & dosage | Urea - therapeutic use | Piperidines - therapeutic use | Piperidines - adverse effects | Urea - adverse effects | Benzodiazepines - administration & dosage | Benzodiazepines - adverse effects | Psychotic Disorders - drug therapy | Clozapine - adverse effects | Benzodiazepines - therapeutic use | Practice Guidelines as Topic
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 10/2018, Volume 70, Issue 10, pp. 1357 - 1368
Journal Article